Understanding how specific RNA elements control protein production in cancer cells
Translational control by 5'-UTR elements
This study is looking at how specific parts of RNA in cancer cells affect how proteins are made, which could help us understand how cancer cells change their protein production and lead to new treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11007223 on NIH RePORTER |
What this research studies
This research investigates how certain regions of RNA, specifically the 5' untranslated regions (5' UTRs), influence the production of proteins in cancer cells. By examining the recruitment of ribosomes to these RNA segments, the study aims to uncover the mechanisms that lead to variations in protein synthesis. The approach combines advanced biochemical techniques and genetic studies to identify key elements that regulate this process. Patients may benefit from insights gained into how cancer cells adapt their protein production, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer, particularly those whose tumors exhibit changes in RNA usage.
Not a fit: Patients with non-cancerous conditions or those whose tumors do not show alterations in 5' UTR usage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target protein synthesis in cancer cells, improving patient outcomes.
How similar studies have performed: Previous research has shown that understanding RNA elements can lead to significant advancements in cancer treatment, suggesting a promising avenue for this investigation.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Niederer, Rachel O. — University of Michigan at Ann Arbor
- Study coordinator: Niederer, Rachel O.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.